RxDoctor Payments Data

Erika Ugianskis, MD

Vascular & Interventional Radiology · Lafayette, INNPI 1184608929

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,500 of the $43,176 with a category attached, or 84.5%. Terumo Medical Corporation accounts for 90.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $15,675 and has fallen 90.1% since, to $1,546 in 2025.

$43,176in general payments, 2019–2025

Across 227 payments — averaging $190.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Medical Corporation$39K
  • Inari Medical, Inc.$2K
  • Stryker$890
  • Endologix LLC$507
  • Medtronic$392
  • Boston Scientific$151
  • plus $441 from 11 others

What the payments were for

  • Consulting fees$36,50085%
  • Travel & lodging$1,4363%
  • Food & beverage$5,24012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,176 in reported general payments places this provider in the 75th percentile of 74 vascular & interventional radiology providers in Indiana.

See all vascular & interventional radiology providers in Indiana

Medicare billing

Part B allowed, 2024
$137,598
Medicare patients
808
Services billed
5,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium18$273
ClopidogrelClopidogrel Bisulfate38$216
Cilostazol11$135

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →